Callio raised $187M in a series A funding round to advance its biopharma initiatives.
Mar 03, 2025•10 months ago
Amount Raised
$187 Million
Round Type
series a
Description
Callio completed a $187 million series A funding round, contributing to the trend of increasing venture capital funding within the biopharma sector in 2024. This round reflects a portion of the $25.3 billion raised by biopharmaceutical companies as reported by the NVCA.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech